IL1B and cancer: Form a long-term “training imprint”, significantly enhancing phagocytic ability, cytotoxicity and the secretion capacity of pro-inflammatory cytokines such as IL-1β and TNF-α; In cancer applications, TI inducers represented by BCG vaccines have performed outstandingly.